Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures

American Journal of Rhinology and Allergy

Volumn 27, Issue 1, 2013, Pages 18-23

  Cho, Jung Sun ^a   Moon, You Mi ^a   Park, Il Ho ^a   Um, Ji Young ^a   Kang, Ju Hyung ^a   Kim, Tae Hoon ^a   Lee, Sang Hag ^a   Kang, Hee Joon ^a   Lee, Heung Man ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE INHIBITOR; HISTONE H4; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRICHOSTATIN A;

ADULT; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SAFETY; ENDOSCOPIC SINUS SURGERY; ENZYME INHIBITION; EPIGENETICS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENETIC REGULATION; HISTONE ACETYLATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MORPHOLOGY; MYOFIBROBLAST; NICK END LABELING; NOSE POLYP; ORGAN CULTURE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETYLATION; ACTINS; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FIBRONECTINS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MYOFIBROBLASTS; NASAL POLYPS; ORGAN CULTURE TECHNIQUES; REPRESSOR PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84876051484     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3827     Document Type: Article

References (32)

1. Pawankar R. Nasal polyposis: An update: Editorial review. Curr Opin Allergy Clin Immunol 3:1-6, 2003.
2. Larsen PL, Tos M, Kuijpers W, and van der Beek JM. The early stages of polyp formation. Laryngoscope 102:670-677, 1992.
3. Norlander T, Westrin KM, Fukami M, et al. Experimentally induced polyps in the sinus mucosa: A structural analysis of the initial stages. Laryngoscope 106:196-203, 1996.
4. Hwang KS, Park IH, Choi H, et al. Increased expression of angiogenin in nasal polyps. Am J Rhinol Allergy 25:e23-e26, 2011.
5. Nakagawa T, Yamane H, Nakai Y, et al. Comparative assessment of cell proliferation and accumulation of extracellular matrix in nasal polyps. Acta Otolaryngol Suppl 538:205-208, 1998.
6. Lee JH, Chung SW, Park IH, et al. Expression of extracellular matrix metalloproteinase inducer in nasal polyps. Am J Rhinol Allergy 24:127-131, 2010.
7. Cho JS, Moon YM, Park IH, et al. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts. Clin Exp Allergy 42:872-882, 2012.
8. Bartram U, and Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 125:754-765, 2004.
9. Blobe GC, Schiemann WP, and Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358, 2000.
10. Border WA, and Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994.
11. Vaughan MB, Howard EW, and Tomasek JJ. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 257:180-189, 2000.
12. Wang QP, Escudier E, Roudot-Thoraval F, et al. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 107:926-931, 1997.
13. Lee HM, Kang HJ, Park HH, et al. Effect of peroxisome proliferatoractivated receptor gamma agonists on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Ann Otol Rhinol Laryngol 118:721-727, 2009.
14. Watelet JB, Claeys C, Perez-Novo C, et al. Transforming growth factor beta1 in nasal remodeling: Differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 18:267-272, 2004.
15. Bonasio R, Tu S, and Reinberg D. Molecular signals of epigenetic states. Science 330:612-616, 2010.
16. Barnes PJ, Adcock IM, and Ito K. Histone acetylation and deacetylation: Importance in inflammatory lung diseases. Eur Respir J 25:552- 563, 2005.
17. Adcock IM, Tsaprouni L, Bhavsar P, and Ito K. Epigenetic regulation of airway inflammation. Curr Opin Immunol 19:694-700, 2007.
18. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12:599-606, 1998.
19. Komorowsky C, Ocker M, and Goppelt-Struebe M. Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors. J Cell Mol Med 13:2353-2364, 2009.
20. Rombouts K, Niki T, Greenwel P, et al. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp Cell Res 278:184-197, 2002.
21. Sharma A, Mehan MM, Sinha S, et al. Trichostatin a inhibits corneal haze in vitro and in vivo. Invest Ophthalmol Vis Sci 50:2695-2701, 2009.
22. Niki T, Rombouts K, De Bleser P, et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 29:858-867, 1999.
23. Choi JH, Oh SW, Kang MS, et al. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 35:89-96, 2005.
24. Park SK, Jang WH, and Yang YI. Expression of pro-angiogenic cytokines and their inhibition by dexamethasone in an ex vivo model of nasal polyps. Biochem Biophys Res Commun 379:255-260, 2009.
25. Park SK, Kim HI, and Yang YI. Roles of vascular endothelial growth factor, Angiopoietin 1, and Angiopoietin 2 in nasal polyp. Laryngoscope 119:409-413, 2009.
26. Wang JH, Kwon HJ, Chung YS, et al. Infection rate and virus-induced cytokine secretion in experimental rhinovirus infection in mucosal organ culture: Comparison between specimens from patients with chronic rhinosinusitis with nasal polyps and those from normal subjects. Arch Otolaryngol Head Neck Surg 134:424-427, 2008.
27. Noh H, Oh EY, Seo JY, et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol 297:F729-F739, 2009.
28. Glenisson W, Castronovo V, and Waltregny D. Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation. Biochim Biophys Acta 1773:1572-1582, 2007.
29. Guo W, Shan B, Klingsberg RC, et al. Abrogation of TGF-beta1- induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol 297:L864-L870, 2009.
30. Hu JH, Jiang J, Ma YH, et al. Enhancement of germ cell apoptosis induced by ethanol in transgenic mice overexpressing Fas Ligand. Cell Res 13:361-367, 2003.
31. Yamada KM, and Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 130:601-610, 2007.
32. Kook H, Lepore JJ, Gitler AD, et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest 112:863-871, 2003.